Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
Researchers sought to determine an association between people with hearing loss, their hearing aid use, and the possibility of an increased risk of dementia or Alzheimer disease.
Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
A new expert consensus was released by the American Academy of Neurology reviewing the currently available evidence on the efficacy and safety of antiamyloid monoclonal antibodies for the treatment of...
Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.
Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.
Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.
The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
